Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development and characterization of a rat model for locally recurring mammary tumors: sensitivities to 5-fluoro-2'-deoxyuridine, adriamycin, and X-irradiation

Journal Article · · Cancer Res.; (United States)
OSTI ID:7071984
Local recurrence occurs in 4-47% of breast cancer patients and is often associated with development of metastatic foci and resistant cell populations. Thus, recurrent breast cancer indicates a poor prognosis for the patient. Local tumor-derived 13762NF rat mammary adenocarcinoma cell clone MTF7(T20) was injected into the inguinal mammary fat pad and allowed to grow before surgical excision. Individual locally growing (primary) tumors were removed and established in short-term tissue culture. Corresponding local recurrences were excised after regrowth and established in short-term tissue culture. All sublines were tested for in vitro sensitivities to 5-fluoro-2'-deoxyuridine, Adriamycin, and ionizing X-irradiation. Using a clonogenic colony formation assay, responses of individual sublines ranged from 85 to 1500 ng/ml for Adriamycin and 65 to 10,000 nM for FdUrd. Some recurrences were significantly more resistant while others were more sensitive than the corresponding primary tumor lines. All recurrences had smaller 90% lethal dose values than the corresponding parent or primary tumor in response to Adriamycin; whereas, to 5-fluoro-2'-deoxyuridine, 90% lethal dose values revealed that most lines were quite resistant. Statistically significant differences in radiation survival were observed only for lines LR1a and LR5 (more sensitive). There was no apparent correlation between sensitivities to chemotherapy agents or X-irradiation and experimental metastatic potential in LR sublines. These dose-response data indicate that locally recurrent tumors are frequently, but not always, different from the original primary tumor in response to chemotherapy agents and ionizing X-irradiation.
Research Organization:
Upjohn Company, Kalamazoo, MI (USA)
OSTI ID:
7071984
Journal Information:
Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 48:16; ISSN CNREA
Country of Publication:
United States
Language:
English

Similar Records

Phase I-II study of concurrent irradiation and multi-drug chemotherapy in advanced carcinoma of the breast: a pilot study by the Southeastern Cancer Study Group
Conference · Wed Aug 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5236627

Radiation response of drug-resistant variants of a human breast cancer cell line
Journal Article · Thu Jun 01 00:00:00 EDT 1989 · Radiation Research; (USA) · OSTI ID:5401487

Heterogeneity in induced thermal resistance of rat tumor cell clones
Journal Article · Mon Oct 31 23:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5176696